16:35 EDT Biodexa Pharmaceuticals files to sell 1.28B ordinary shares for holders
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BDRX:
- Biodexa Announces Positive Top Line Phase I Clinical Trial Results for Diffuse Midline Glioma and Provides R&D Update
- Biodexa announces results for Phase 1 study of MTX110, update for Tolimidone
- Alibaba downgraded, Disney upgraded: Wall Street’s top analyst calls
- Biodexa Reports 12 Month Survival in MAGIC-G1 Study of MTX110 in Recurrent Glioblastoma Patients
- Biodexa Pharmaceuticals reports 12 month survival in MAGIC-G1 study of MTX110